U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07331987) titled 'Efficacy and Safety of Probiotics for Anxiety Depression' on Dec. 30, 2025.
Brief Summary: This randomized, double-blind, placebo-controlled study will enroll 60 individuals with mild-to-moderate anxiety depression. Following a 3-month intervention and a 1-month follow-up period, the study aims to: 1) evaluate the efficacy of probiotics by comparing anxiety, depression, and sleep scores to baseline; and 2) investigate the safety and underlying mechanisms by analyzing changes in serum biomarkers, gut microbiota, and related metabolites.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Anxiety Depression
Intervent...